Publicaciones en colaboración con investigadoras/es de Hospital Universitario Virgen del Rocío (15)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

    Antioxidants, Vol. 12, Núm. 1

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

    Journal of Controlled Release, Vol. 342, pp. 81-92

2021

  1. Long runs of homozygosity are associated with Alzheimer’s disease

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Traditional medicinal uses of the Eurasian wild grapevine in the Iberian Peninsula

    Anales del Jardín Botánico de Madrid, Vol. 77, Núm. 2

2019

  1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347

  2. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis

    Hepatology, Vol. 70, Núm. 2, pp. 547-562

2018

  1. CCR-CARESS score for predicting operative mortality in patients with colorectal cancer

    British Journal of Surgery, Vol. 105, Núm. 13, pp. 1853-1861

2016

  1. Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project

    BMC Cancer, Vol. 16, Núm. 1

2014

  1. Predicting response and survival in chemotherapy-treated triple-negative breast cancer

    British Journal of Cancer, Vol. 111, Núm. 8, pp. 1532-1541

2013

  1. 1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death

    Translational Psychiatry, Vol. 3, Núm. 1

  2. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: Results from the GEICAM/2003-02 study

    Journal of Clinical Oncology

2012

  1. Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia

    Journal of Biological Chemistry, Vol. 287, Núm. 12, pp. 9651-9658

2008

  1. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer

    Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814